Traws Pharma Files 8-K
Ticker: TRAW · Form: 8-K · Filed: Apr 7, 2025 · CIK: 1130598
| Field | Detail |
|---|---|
| Company | Traws Pharma, Inc. (TRAW) |
| Form Type | 8-K |
| Filed Date | Apr 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, routine-filing, corporate-update
TL;DR
Traws Pharma filed a routine 8-K, no major news.
AI Summary
Traws Pharma, Inc. filed an 8-K on April 7, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The company, formerly known as Onconova Therapeutics, Inc., is incorporated in Delaware and headquartered in Newtown, PA. This filing does not appear to contain specific financial figures or significant operational updates beyond routine reporting.
Why It Matters
This 8-K filing indicates routine corporate reporting by Traws Pharma, Inc. to the SEC, without disclosing immediate material events.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and financial statements, not indicating any immediate material risks or changes.
Key Players & Entities
- Traws Pharma, Inc. (company) — Registrant
- Onconova Therapeutics, Inc. (company) — Former company name
- April 7, 2025 (date) — Date of earliest event reported
- 12 Penns Trail Newtown, PA 18940 (location) — Company address
FAQ
What is the primary purpose of this 8-K filing for Traws Pharma, Inc.?
The filing is a Current Report on Form 8-K, reporting 'Other Events' and 'Financial Statements and Exhibits' as of April 7, 2025.
When was the earliest event reported in this filing?
The earliest event reported was on April 7, 2025.
What was Traws Pharma, Inc. formerly known as?
Traws Pharma, Inc. was formerly known as Onconova Therapeutics, Inc.
Where is Traws Pharma, Inc. located?
The company's business address is 12 Penns Trail, Newtown, PA 18940.
What is the SIC code for Traws Pharma, Inc.?
The Standard Industrial Classification (SIC) code for Traws Pharma, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 7, 2025 regarding Traws Pharma, Inc. (TRAW).